Conservative therapy for the management of cardiac implantable electronic device infection  by Sekiguchi, Yukio
Journal of Arrhythmia 32 (2016) 293–296Contents lists available at ScienceDirectJournal of Arrhythmiahttp://d
1880-42
(http://c
Abbre
n Tel./
E-mjournal homepage: www.elsevier.com/locate/joaReviewConservative therapy for the management of cardiac implantable
electronic device infection
Yukio Sekiguchi, MDn
Cardiovascular Division, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki 305-8575, Japana r t i c l e i n f o
Article history:
Received 14 May 2015
Received in revised form
12 August 2015
Accepted 1 October 2015
Available online 19 November 2015
Keywords:
Cardiac implantable electronic device
Infection
Antibiotic therapy
Device extractionx.doi.org/10.1016/j.joa.2015.09.012
76/& 2015 Japanese Heart Rhythm Society. Pu
reativecommons.org/licenses/by-nc-nd/4.0/).
viations: CIED, cardiac implantable electronic
fax: þ81 29 853 3143.
ail address: yseki@md.tsukuba.ac.jpa b s t r a c t
Along with the increased frequency of implantation, the incidence of cardiac implantable electronic
device (CIED) infection, which can have serious or fatal complications, has also increased. Although
several successful conservative therapies for CIED infection have been reported, retained infected devices
remain a source of relapse, which is closely related to a higher mortality rate. Presently, complete
hardware removal is initially recommended for infected CIED patients, and indications for conservative
therapy, including continuous administration of antibiotics, require careful consideration.
On the other hand, complete removal is not required for superﬁcial or incisional infection at the
device pocket if an infection does not involve the device, but the patient should be closely followed for
progression to deeper infection, which would require extraction.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. This is an open access article under the
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Treatment with a cardiac implantable electronic device (CIED),
including a permanent pacemaker (PPM) or implantable cardioverter–
deﬁbrillator (ICD), is very useful. At present, an ICD is needed not only
to rescue survivors of life-threating ventricular arrhythmias, but is also
ﬁrst-line primary prevention to save patients with marked cardiac
dysfunction. Moreover, medical technology for resynchronization
therapy has advanced, with a resulting increased rate of device
implantation [1,3]. Along with the increase in device implantation, theblished by Elsevier B.V. This is an
deviceincidence of CIED infection, which can have serious or fatal compli-
cations, has also increased [2,4–7]. Prutkin et al. reported that a total
of 3390 (1.7%) out of 200,909 implanted ICDs developed a device
infection within six months [6]. Other studies have reported a similar
rate of CIED infection (0.7–2.2%) [5,8–10].
The management of infected CIED patients is difﬁcult, and
requires special knowledge and effort by physicians. Intensive
treatment of CIED infections is recommended, including admin-
istration of appropriate antibiotics and complete removal of the
infected device [5,11–22]. Consensus reports and statements from
the literature also recommend prompt and complete device
removal in combination with antimicrobial therapy [22–24]. In
this article, we present the role of conservative therapy for the
management of CIED infection.open access article under the CC BY-NC-ND license
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When CIED infection is diagnosed, early complete removal of the
infected device is strongly recommended because of the high asso-
ciation with increased mortality. No prospective randomized studies
have assessed the value of conservative antibiotic therapy alone,
compared with combined complete device removal and administra-
tion of appropriate antibiotics. However, some reports cited the poor
outcome using conservative antibiotic therapy in patients with CIED
infection [11,25]. About 30 years ago, Lewis et al. reported on treat-
ment of patients with permanent pacemaker infections [26]. Thirty-
two patients received conservative antibiotic therapy without removal
of the infected pacing system, which included limited debridement
and irrigation or aspiration of the infected sites. This conservative
therapy failed in all, but one of the 32 patients, and complete removal
of the device system was needed in 31. Molina et al. subsequently
reported the outcome of management in 38 patients with an infected
CIED, including 17 ICDs [27]. Twelve patients received intravenous
antibiotics without removal of the CIED, but with relocation to a dif-
ferent area, with or without aspiration of the infected area. Patients
who received conservative therapy ultimately all remained infected.
Two deaths occurred in these patients. On the other hand, the
remaining 26 CIED patients who underwent primary removal of the
entire device system were completely cured. No deaths occurred in
these patients. These data supported the value of prompt complete
device removal in infected CIED patients.3. Mortality
Although complete removal of an infected CIED is ﬁrst-line ther-
apy, there can be a risk of device removal complications. It was
reported that complications of device extraction were associated with
increased mortality in patients with CIED infections at both 30 days
(hazard ratio [HR]: 4.33, 95% conﬁdence interval [CI]: 1.47–12.70) and
one year (HR: 3.77, 95% CI: 1.88–7.55) [11]. However, delayed device
removal was associated with a 3-fold increase in one-year mortality,
and antibiotic therapy without device removal was associated with a
7-fold increase in 30-day mortality, compared to immediate device
removal in the previous paper. Margey et al. also described outcomes
and mortality in infected CIED patients [5]. Of 39 (82%) patients, 32
underwent device extraction, and complete device removal was
accomplished in 27 (84%). Of these, none relapsed, and mortality was
7.4% during a median follow-up period of 36 months. Of those man-
aged with only generator removal or conservative therapy, relapse
occurred in 8 of 12 (67%), with mortality occurring in 8.4%. Using data
on patients with infective endocarditis and a cardiac device, Athan et
al reported that 28 of 141 (19.9%) who underwent device removal
during the index hospitalization died at one year, compared with 13 of
34 (38.2%) who did not undergo device removal (HR: 0.42, 95% CI:
0.22–0.82), which suggested that device removal was associated with
improved survival at one year [12].4. Possibility of successful conservative therapy
Some patients have severe complicated medical problems and are
considered too ill to tolerate aggressive surgical intervention. In
addition, some patients refuse surgery, or have a limited life span. In
such cases, conservative treatment has been attempted. In 1985,
Garcia-Rinaidi et al. successfully treated exposed pacemakers relo-
cated to deeper subfascial planes without relapse of infectious signs in
10 patients [28]. They concluded that subfascial relocation of a prop-
erly functioning pacemaker generator should be considered as an
alternative to complete replacement of the unit. Hurst et al. also
reported that 19 infected or extruded pacemaker patients weretreated with local debridement and insertion of a closed irrigation
system using solutions of tyloxapol and tobramycin [29]. In order to
achieve successful treatment, they insisted on careful debridement of
the infected pocket and large pocket space to ensure adequate closure
without tension. Using this method, they have been successful in
salvaging infected pacemaker pockets, and all 19 patients healed
without complications after treatment (the maximum follow-up
period was 70 months).
Clinical data on 51 patients with intravascular device-related
infections who were administered long-term suppressive antibiotic
therapy were also reported [30]. The categories included vascular graft
infections in 30 (59%) patients, prosthetic valve endocarditis in 12,
pacemaker-related infections in 5, aortic graft infections in 3, central
venous catheter infections in 3, and venous ﬁlter infection in one.
Therapy duration ranged from 3 months to 10 years. Of 41 followed-
up patients, 3 (7%) had an infection relapse while on long-term
antibiotic therapy. Three patients died, including one who had an
infection relapse and died of the infection. Drug side effects occurred
in the other 3 patients. The report stated that long-term antibiotic
therapy was well-tolerated and efﬁcacious in nonsurgical candidates.
Segreti et al. reviewed 18 patients with infected orthopedic prostheses
who had been treated with long-term antibiotic therapy. Although
side effects related to antibiotics occurred in 22%, 15 (83%) patients
with a mean follow-up of 5 years had a good response to suppression
of infection and could retain a functional prosthesis [31]. Ortler et al.
experienced the case of one epileptic patient implanted with an
infected vagus nerve stimulator system who underwent successful
open wound treatment without removal of the system [32]. They
reported that the deep wound was initially opened and debrided.
With continuous antibiotic therapy and daily rinsing with 3% hydro-
gen peroxide solution and 5% saline, granulation tissue gradually
appeared. In this case, relapse of infection never occurred during a
follow-up of 1 year. The value of local treatment with 3% hydrogen
peroxide for prevention of foreign body infection has been previously
reported [33]. Of 990 CIEDs treated with 3% hydrogen peroxide during
the implant procedure, 2 (0.2%) developed an infection, which was a
signiﬁcantly reduced infection rate compared to that of CIEDs treated
without hydrogen peroxide during implantation (1.83%, po0.05).
Although conservative therapies might be useful in limited cases,
retained infectious devices have a risk of mortality. Additionally, these
papers were published more than 10 years ago, and medical tech-
nology has advanced since then. The excimer laser has also been used
for CIED lead removal in many countries. If possible, initial complete
hardware removal is strongly recommended, and the indications for
conservative antibiotic therapy for CIED infections should be deter-
mined with great caution.5. Recent studies
In 2010, Satsu et al. reported the use of a vacuum-assisted
wound closure (VAC) system as an option for treating an infected
device [34]. The VAC system is comprised of polyurethane foam
with an evacuation tube, a vacuum pump, and adhesive drape.
Treatment with VAC has been reported to be an efﬁcacious mod-
ality for chronic and difﬁcult wounds [35,36]. After opening the
wound, the polyurethane is cut and positioned on the defect area,
with connection of the evacuation tube. The wound is then cov-
ered with an adhesive drape, and suction is continued with a
negative pressure of 100 mmHg. The wound is treated by changing
the foam every 2 or 3 days until healing occurs, or the incision is
sutured when granulation appears. According to this paper,
infections never relapsed after treatment with VAC in all 4 patients
for 5–15 months, and CIED infection healed without complete
removal of the pacemaker system in 2 patients.
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wound after removal of the cardiac device system and debride-
ment of the pocket (Fig. 1).6. Superﬁcial or incisional infection
According to the Heart Rhythm Society expert consensus
report, CIED removal is not recommended for a superﬁcial or
incisional infection without involvement of the device or lead
(class III indication) (Fig. 2) [24]. However, it is difﬁcult toFig. 1. VAC system (Kinetic Concepts, Inc., San Antonio, TX, USA). The VAC system comp
(panels A and B). The sponge is cut and positioned on the defect area with connection of
continued with negative pressure (panel C).
Fig. 2. A case of superﬁcial incisional infection. Fourteen days after an operation to exch
line (panel A). Inﬂammatory markers became elevated, and intravenous antibiotics wer
month later, the incisional wound was closed, with complete resolution of inﬂammatory
follow-up period of 6 months. The incisional wound remained clear (panel C).distinguish whether a superﬁcial pocket infection might have
extended through the device. It was reported that the intravas-
cular parts of leads yielded positive cultures in 79% of 105 study
patients who had local pocket complications, which were asso-
ciated with a risk of progression to systemic infection [37]. Chamis
et al. reported no local signs or symptoms related to pocket
infection in 60% of patients (9 of 15) with conﬁrmed CIED infec-
tions [38]. When superﬁcial or incisional infection of a CIED
occurs, conservative antibiotic therapy may be administered as
needed, and the patient should be closely followed for progression
to a deeper infection, which would require extraction.rises of a sponge with an evacuation tube, an adhesive drape, and a vacuum pump
the evacuation tube. The wound is covered with the adhesive drape, and suction is
ange a pacemaker device, wound dehiscence was observed at the sutured incision
e administered for 11 days in conjunction with daily wound irrigation. About one
markers (panel B). There was no fever or inﬂammatory marker elevation during a
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tron emission tomography–computed tomography (FDG-PET/CT)
could diagnose CIED infections [13,39]. In some suspected CIED
cases, this new imaging modality may be useful in differentiating a
superﬁcial from a systemic infection, and may lead to appropriate
therapy.7. Conclusion
Although several successful conservative therapies for CIED infec-
tion have been reported, retained infectious devices remain a source
of relapse, which is closely related to a higher mortality rate. Presently,
complete hardware removal is initially recommended for infected
CIED patients, and the indication of conservative therapy for CIED
infections should be determined with great caution.
The absolute rate of device infection has recently increased. Fur-
ther strategies for reducing CIED infection should be considered.Conﬂict of interests
All authors declare no conﬂict of interest related to this study.References
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